Literature DB >> 23954821

Mitochondrial-related gene expression profiles suggest an important role of PGC-1alpha in the compensatory mechanism of endemic dilated cardiomyopathy.

Shu-Lan He1, Wu-Hong Tan, Zeng-Tie Zhang, Feng Zhang, Cheng-Juan Qu, Yan-Xia Lei, Yan-He Zhu, Han-Jie Yu, You-Zhang Xiang, Xiong Guo.   

Abstract

Keshan disease (KD) is an endemic dilated cardiomyopathy with unclear etiology. In this study, we compared mitochondrial-related gene expression profiles of peripheral blood mononuclear cells (PBMCs) derived from 16 KD patients and 16 normal controls in KD areas. Total RNA was isolated, amplified, labeled and hybridized to Agilent human 4 × 44k whole genome microarrays. Mitochondrial-related genes were screened out by the Third-Generation Human Mitochondria-Focused cDNA Microarray (hMitChip3). Quantitative real-time PCR, immunohistochemical and biochemical parameters related mitochondrial metabolism were conducted to validate our microarray results. In KD samples, 34 up-regulated genes (ratios ≥ 2.0) were detected by significance analysis of microarrays and ingenuity systems pathway analysis (IPA). The highest ranked molecular and cellular functions of the differentially regulated genes were closely related to amino acid metabolism, free radical scavenging, carbohydrate metabolism, and energy production. Using IPA, 40 significant pathways and four significant networks, involved mainly in apoptosis, mitochondrion dysfunction, and nuclear receptor signaling were identified. Based on our results, we suggest that PGC-1alpha regulated energy metabolism and anti-apoptosis might play an important role in the compensatory mechanism of KD. Our results may lead to the identification of potential diagnostic biomarkers for KD in PBMCs, and may help to understand the pathogenesis of KD.
© 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Immunohistochemical (IHC); Ingenuity systems pathway analysis (IPA); Keshan disease (KD); Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1alpha); Significance analysis of microarrays (SAM)

Mesh:

Substances:

Year:  2013        PMID: 23954821     DOI: 10.1016/j.yexcr.2013.07.018

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  5 in total

Review 1.  The emergence of the mitochondrial genome as a partial regulator of nuclear function is providing new insights into the genetic mechanisms underlying age-related complex disease.

Authors:  Martin P Horan; David N Cooper
Journal:  Hum Genet       Date:  2013-12-04       Impact factor: 4.132

2.  Serum biomarkers of Keshan disease assessed using a protein profiling approach based on ClinProt technique.

Authors:  YouZhang Xiang; Qun Xu; WuHong Tan; ShuLan He; XiaoWei Shi; WenMing Zhang; Jing Wang; XiuHong Wang; WeiJuan Ma
Journal:  Protein J       Date:  2014-08       Impact factor: 2.371

3.  Metabolism of arachidonic acid by the cytochrome P450 enzyme in patients with chronic Keshan disease and dilated cardiomyopathy.

Authors:  Bing Zhou; Shulan He; X I Wang; Xiaolong Zhen; Xiaohui Su; Wuhong Tan
Journal:  Biomed Rep       Date:  2015-12-31

4.  A Spatial Ecological Study on Serum Selenium and Keshan Disease in Heilongjiang Province, China.

Authors:  Xu Liu; Yanan Wang; Shan Han; Yiyi Zhang; Yuanjie Zou; Shengqi Su; Huihui Zhou; Xiao Zhang; Hong Liang; Jie Hou; Tong Wang
Journal:  Biol Trace Elem Res       Date:  2020-11-07       Impact factor: 3.738

5.  Prediction of co-expression genes and integrative analysis of gene microarray and proteomics profile of Keshan disease.

Authors:  Sen Wang; Rui Yan; Bin Wang; Peiru Du; Wuhong Tan; Mikko J Lammi; Xiong Guo
Journal:  Sci Rep       Date:  2018-01-10       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.